Business Context and Reporting Period
This Form 8-K is a current report filed by Landec Corporation (not Lifecore Biomedical, Inc.) on October 11, 2013, regarding events occurring on October 10, 2013. The filing details the results of the Company's Annual Meeting of Stockholders and the approval of a new equity compensation plan.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and equity plan approvals rather than financial performance metrics.
Material Changes and Corporate Actions
- 2013 Stock Incentive Plan Approval: Stockholders approved the 2013 Stock Incentive Plan, which became effective immediately. This plan supersedes the 2009 Stock Incentive Plan and all other existing equity award plans.
- Plan Details: The plan authorizes the issuance of up to 2,000,000 shares of common stock for stock options, stock grants, stock units, and stock appreciation rights. It has a seven-year term.
- Director Elections: Four Class 2 directors (Dean Hollis, Robert Tobin, Nicholas Tompkins, and Tonia Pankopf) were elected to two-year terms.
- Auditor Ratification: Stockholders ratified the appointment of Ernst & Young LLP as the independent registered public accounting firm for the fiscal year ending May 25, 2014.
- Executive Compensation: Stockholders approved a non-binding advisory proposal regarding executive compensation.
Voting Results Summary
| Proposal | Votes For | Votes Against | Abstain |
|---|---|---|---|
| Election of Directors (Aggregate) | ~82.2M | ~2.2M | N/A |
| Ratification of Auditor | 23,414,538 | 651,000 | 16,674 |
| 2013 Stock Incentive Plan | 18,229,455 | 2,846,345 | 27,742 |
| Executive Compensation (Say-on-Pay) | 20,772,500 | 251,186 | 79,856 |
Outlook, Risks, and Contingencies
The filing does not contain specific management commentary on future financial outlook, risks, or contingencies. The primary operational change is the shift to the new 2013 Stock Incentive Plan, which includes specific annual award limits for recipients (e.g., 500,000 shares for options, 250,000 shares for grants/units).
Key Facts for Investor Verification
- Verify the exact number of shares authorized under the new 2013 Stock Incentive Plan (2,000,000) and the specific vesting terms in the full plan document (Exhibit 99.1).
- Confirm the effective date of the new plan (October 10, 2013) and the cessation of awards under the 2009 plan.
- Note the significant number of broker non-votes (2,978,670) on director elections and the stock incentive plan, indicating shares held in street name where brokers lacked discretionary voting power.
- Review the full text of the 2013 Stock Incentive Plan to understand the specific eligibility criteria and amendment rights reserved by the Board of Directors.